Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2544137 | Journal of the American Pharmacists Association | 2007 | 10 Pages |
Abstract
Leaflet quality varied more among the three countries than within each country, reflecting the regulatory context. The Australian leaflets performed well across all criteria, whereas the U.S. leaflets had significant shortcomings with the omission of vital information for the safe and effective use of the medications. A repeat survey is needed to assess whether new legislation and guidance in all three countries successfully addresses the shortcomings identified.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
D.K. Theo (Professor of Pharmacy Practice), Bonnie (Professor), Peter (Senior Lecturer), Parisa (Senior Lecturer, Faculty of Pharmacy), M. Brooke (Lecturer in Risk and Terror), Michelle (Education and Quality Assurance Program Officer),